Background

Several blood parasites, such as Babesia spp., infect erythrocytes in dogs and may lead to hemolytic anemia. Babesiosis in domestic dogs and wild canids is caused by several vector-borne, geographically widespread hemoprotozoan parasites belonging to the Babesia and Theileria genera, and the most commonly reported species in Europe include B. canis, B. gibsoni, B. vogeli and T. annae[1, 2]. T. annae is also called Babesia microti-like or Spanish isolate/agent because it is endemic in Galicia, Northwestern Spain. T. annae has also been identified in Portugal, Croatia and in one dog in North America[27]. Ixodes hexagonus is the likely vector of T. annae in Northwest Spain, but other ticks such as Rhipicephalus sanguineus, Ixodes ricinus and Dermacentor spp. have also been proposed as possible transmitters[2, 8, 9]. A vertical (transplacental) transmission of T. annae is also likely as it has been detected in a German shepherd bitch and her 2-month old pup[7]. T. annae has also been detected in a dog confiscated from dogfighting operations in North America suggesting that T. annae may be transmitted by dog bites as occurs with B. gibsoni[6].

T. annae causes severe illness, and dogs may present with weakness, fever, lethargy, hemoglobinuria, tachycardia and tachypnea[2]. Laboratory findings in dogs from Northwest Spain include moderate to severe regenerative anemia (hematocrit below 31%), with marked reticulocytosis. Moderate to severe thrombocytopenia is a common finding, with 50% of the dogs having platelet counts below 23 × 109/L. Leukocytosis and evidence of hepatic disease are uncommon. Azotemia has been recorded in 10–36% of dogs infected with T. annae at the time of diagnosis, which is a poor prognostic marker, with a 22% fatality rate within a week post diagnosis[5, 10, 11].

T. annae appears as a small (less than 2 μm), single, ring-shaped intraerythrocytic piroplasm in blood smears from infected canids. Mostly, the parasitemia is of low level[5, 12]. Specific diagnosis of the parasite is confirmed by polymerase chain reaction (PCR) analysis of blood samples. 18S RNA gene has been used for conventional and nested PCR[5, 6, 11, 12]. A reverse line blot (RBL) assay has recently been developed that simultaneously detects and separates the major vector-borne dog pathogens, including T. annae, in Southern Europe and the Middle East[4].

T. annae appears to be resistant and poorly responds to imidocarb dipropionate (Imizol, at 5–6.6 mg/kg)[2, 11]. Therefore, other drugs, such as Epoximicin and Artesunate, are being investigated as potential therapeutics[13, 14]. T. annae infection in dogs has been hypothesized to be lifelong[1]. Unless I. ricinus could serve as a vector, T. annae is not likely to become endemic in Sweden because of an absence of a suitable vector. However, global warming and increased dog traveling and importation may potentially change the distribution patterns of European tick populations, potentially leading to spread of infectious agents, such as T. annae, to Scandinavia.

The purpose of this first report of T. annae infection in a dog in Scandinavia is to alert Scandinavian veterinarians of the presence of this infection. It should be a differential diagnosis in dogs with regenerative, hemolytic anemia. This first case report of T. annae infection was a 12-week old Swedish, part pit bull puppy with severe regenerative anemia. It was unexpected to find this hemoprotozoan in such a young, Swedish dog and the parasite species had not been diagnosed in Scandinavia previously.

Case presentation

A 12-week-old, mixed pit bull, male dog was presented to the University Animal Hospital of the Swedish University of Agricultural Sciences, January 2nd 2013, with a history of suddenly appearing lethargic. The puppy was acquired in Sweden four weeks previously and reportedly was not in any contact with dogs which had traveled out of Sweden. It had appeared normal and active until the day before presentation. There was no history of previous illness or medication. The dog had been vaccinated at 8 weeks of age, presumably against canine distemper, parvovirus and infectious canine hepatitis. Physical examination indicated pale mucous membranes, a mild holosystolic heart murmur, mild peripheral lymphadenomegaly and suspected splenomegaly. The owner did not reported any problem with the dog’s mother.

A blood sample for complete blood count (CBC) was collected in EDTA, and analyzed within two hours (Advia 2120 hematology system, Siemens Healthcare Diagnostics, Erlangen, Germany) and blood smears were prepared, air-dried, stained with Giemsa and evaluated microscopically (Table 1). Consequently, the dog was diagnosed with a severe, moderately regenerative, macrocytic, hypochromic anemia.

Table 1 Hematology data from a puppy with proven Theileria annae infection

A small protozoan parasite was identified in approximately 2% of the erythrocytes. It was approximately 1–2 μm in diameter and appeared as a dark dot (nucleus) with a variable amount of visible cytoplasm (Figures 1 and2). Based on its small size, and because B. gibsoni was recorded previously in Sweden, the protozoan was initially assumed to be B. gibsoni. No spherocytes, autoagglutination or signs of oxidative damage such as Heinz bodies or eccentrocytes were observed on blood smear evaluation. There was no apparent hemolysis in EDTA-plasma. The puppy had a mild neutrophilia with a left shift indicating inflammation. The neutrophils did not have any toxic changes. Platelet aggregates were observed on blood smear examination, precluding an accurate automated platelet count, which recorded thrombocytopenia. Visual estimation from the blood smear suggested a mild thrombocytopenia.

Figure 1
figure 1

Blood smear photomicrograph; Blood smear photomicrograph with Giemsa stain illustrates anisocytosis, 2 polychromatophils and 1 erythrocyte with Theileria annae (arrow). Original magnification 1000 ×.

Figure 2
figure 2

Giemsa stained blood smear photomicrograph; Giemsa stained blood smear photomicrograph shows a Theileria annae (arrows) in the two lower center erythrocytes and one in the upper right polychromatophilic erythrocyte. The lowest cell has a protozoon with more obvious cytoplasm. The protozoa have a similar sized, dark, round nucleus. Original magnification 1000 ×.

A sample for serum chemistry was also collected and analyzed (Architect c4000, Abbott Laboratories, Abbott Park, Illinois, USA). Serum chemistry analyses of hepatic and renal parameters as well as albumin and protein concentrations were unremarkable.

An EDTA blood sample was submitted to the Acarus Laboratory, Molecular Diagnostic Unit, Langford Veterinary Services, Bristol, UK, for molecular identification of the protozoan parasite. DNA was extracted from 100 μl of EDTA blood using the Nucleospin 8 Blood kit (Machery-Nagel, Düren, Germany), according to the manufacturer’s instructions, with elution into 100 μl elution buffer. PCR was then performed using 1 X Qiagen HotStarTaq Master Mix (Qiagen, Crawley, UK), 200nM each of primers (Metabion International AG, Martinsried, Germany) designed to amplify a 450 base pair (bp) product of the 18S rRNA gene of piroplasmas (PiroA1 Forward 5′agg-gag-cct-gag-aga-cgg-cta-cc3′and PiroB Reverse 5′tta-aat-acg-aat-gcc-ccc-aac3′), 5 μl of DNA, made up to final volume of 25 μl with RNase free water. PCR was carried out in a PTC-225 thermal cycler (MJ Research, St. Bruno, Canada) with the following protocol: 95°C 15 min, 40 × 95°C 15 sec, 60°C 20 sec and 72°C 30 sec. PCR products were analysed on a 1.5% Tris acetate-EDTA agarose (Appleton scientific Molecular Grade Agarose) gel with molecular weight markers (BioLine Easy Ladder I, Bioline Reagents Ltd, London, UK). Negative (sterile water) and positive (canine blood confirmed to be infected with Babesia canis) controls were also subjected to DNA extraction and PCR, and were appropriately negative and positive. The PCR product produced using the DNA extracted from the puppy was then purified using the Machery-Nagel Nucleospin Extract II kit according to the manufacturer’s instructions and the DNA quantified for sequencing using the Invitrogen Quant-iT dsDNA Assay kit & the Invitrogen Qubit Flurometer according to manufacturer’s instructions. Ten ng of purified PCR product was sent for DNA sequencing to DNA Sequencing & Services (Dundee, UK), using the PiroA1 Forward and PiroB Reverse primers. The sequence data derived was then BLAST searched (337 bp with the forward primer, 316 bp with the reverse primer) and showed 100% identity with canine T. annae (JX454779.1 Genbank accession no.). There was no evidence of other concurrent piroplasma infections.

The puppy was euthanized soon after initial diagnosis at the owner’s request due to the potential for lifelong infection. The owner declined a postmortem examination. Attempts to contact the dog breeder failed, but Swedish health officials are still making efforts to trace the origin of this infection.

Conclusions

To the authors’ knowledge this is the first case of T. annae infection in Sweden.

This report should alert Scandinavian veterinarians that T. annae infection in dogs should be included as differential diagnosis in cases of regenerative anemia in this region. We can hypothesize, based on the puppy’s young age that the disease was transmitted vertically from its mother. Additionally because T. annae may be transmitted by bites from an infected dog and because the patient was part pit bull terrier, a breed used for dog fighting, we can also hypothesize the mother may have been infected by a bite wound. However, information on this possibility is not available.